Skip to content

Effects of Personal Technology Driven Workplace Wellbeing Intervention Programme on Wellbeing, Productivity (Presenteeism) and Absenteeism - an Intervention Study

Effects of Personal Technology Driven Workplace Wellbeing Intervention Programme on Wellbeing, Productivity (Presenteeism) and Absenteeism - an Intervention Study

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05274529
Acronym
Coachbeat
Enrollment
571
Registered
2022-03-10
Start date
2022-04-12
Completion date
2026-10-31
Last updated
2024-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Occupational Stress, Occupational Burnout

Keywords

workplace, wellbeing, intervention, absenteeism, presenteeism, stress, burnout

Brief summary

In this study the effects of a technology-driven workplace wellbeing intervention programme on employees' wellbeing, productivity (presenteeism) and absenteeism will be studied with the help of mobile applications and remotely conducted questionnaires, different wellbeing intervention periods and HRV based measurements.

Detailed description

The objectives of this study are: 1. To study the effects of a data driven adaptive workplace wellbeing intervention programme on productivity (presenteeism) and absenteeism of the employees. 2. To study the effects of data driven adaptive workplace wellbeing interventions on employees' physical health measures and wellbeing. The secondary objective also includes studying whether the programme generates measurable financial savings. This study is an intervention study where eligible participants will be offered a technologically delivered health promotion intervention which is personalized to their needs both in terms of content and timing within the 12-month intervention period. The outcomes are compared against their pre-intervention levels at both individual and group level. The study has no control group as it is not acceptable for the participating companies to offer participation only to part of their employees based on randomization due to expected positive impact of the intervention. The lack of the control group will be taken into account while analyzing and interpreting the study results. The 12-month intervention period consists of access to Firstbeat Life (HRV & movement measurement based wellbeing service), Aava Medical's Aisti wellbeing assessment and four types of online coaching programmes plus option of no coaching. Every participant has continuous access to Firstbeat Life and Aisti during the entire intervention programme and may use them at any time they so desire. In addition, participants will use the Coachbeat mobile app which is used to instruct and communicate with the participants, to fill in all the study questionnaires at given times, and to promote use of Firstbeat Life and Aisti at given points of the study. Baseline measurements and measurements after 4 and 8 months give recommendations for participation to the online coaching based on Firstbeat Life and Aisti wellbeing assessment. The participants can choose the coaching program based on the recommendation or their own interest. They can participate several coaching programmes during the study. Each coaching programme lasts approximately 3 months.

Interventions

BEHAVIORALPsychological health and flexibility

A remote coaching programme concentrating on psychological health and flexibility

BEHAVIORALWork ability

A remote coaching programme concentrating on work ability

BEHAVIORALSleep and recovery

A remote coaching programme concentrating on sleep and recovery

BEHAVIORALHealthy lifestyle

A remote coaching programme concentrating on healthy lifestyle

Participants also have the option to choose no coaching for the coming 3 month period.

Sponsors

Aisti Health Oy
CollaboratorUNKNOWN
University of Jyvaskyla
CollaboratorOTHER
Tampere University
CollaboratorOTHER
Firstbeat Technologies Oy
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

This is a pre-post type intervention study where baseline measurements are made at 0 months from the study start and follow up measurements are made at 4, 8 ,12, 24 and 36 months.

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

The initial target population consists of generally healthy employees of selected employer companies from information intensive industries and jobs. Inclusion Criteria: * Signed written informed consent * Adequate Finnish or English1 language skills to comprehend study-related instructions and questionnaires. The services and contents are available only in Finnish and English.

Exclusion criteria

* Planned absenteeism from work during the study with \>3mth duration * Use of cardiac pacemaker or history of atrial fibrillation * No access to compatible mobile phone * History of a major cardiovascular event (myocardial infarction, coronary artery bypass graft (CABG), percutaneous coronary intervention (PCI), stroke, or transient ischemic attack) within the previous 6 months

Design outcomes

Primary

MeasureTime frameDescription
The change in work productivity loss (presenteeism) by WLQ0, 4, 8, 12, 24 and 36 months from startThe change in work productivity loss (presenteeism) is assessed by repeating Work Limitations Questionnaires (WLQ). WLQ results are on a scale from 0 to 100 where 0 means no limitations to work (=best result) and 100 means the most limitations to work (=worst result)
The change in work productivity loss (presenteeism) by HPQ0, 4, 8, 12, 24 and 36 months from startThe change in work productivity loss (presenteeism) is assessed by repeating Health and Work Performance Questionnaires (HPQ). HPQ scale goes from 0 to 10 where 10 means the best health and work performance.
The change in work ability0, 12, 24 and 36 months from startThe change in work ability is assessed by repeating work ability index (WAI) questionnaires. WAI scores are on a scale from 7 to 49 points where 7 is the poorest and 49 is the best work ability.
The change in sick-leaves (absenteeism) by absenteeism records0, 12, 24 and 36 months from startThe change in sick-leaves (absenteeism) are assessed via employer absenteeism records
The change in sick-leaves (absenteeism) by HPQ0, 12, 24 and 36 months from startThe change in sick-leaves (absenteeism) are assessed via repeating Health and Work Performance Questionnaires (HPQ). HPQ scale goes from 0 to 10 where 10 means the best health and work performance.
The change in sick-leaves (absenteeism) by WAI0, 12, 24 and 36 months from startThe change in sick-leaves (absenteeism) are assessed via repeating work ability index (WAI) questionnaires. WAI scores are on a scale from 7 to 49 points where 7 is the poorest and 49 is the best work ability.

Secondary

MeasureTime frameDescription
The change in autonomic nervous system function and health behaviors based on HRV0, 4, 8, 12, 24 and 36 months from startThe change in autonomic nervous system function and health behaviors is assessed by HRV (heart rate variability)
The change in autonomic nervous system function and health behaviors based on measured stress/recovery0, 4, 8, 12, 24 and 36 months from startThe change in autonomic nervous system function and health behaviors is assessed by measured stress/recovery. Stress & recovery balance is scored on a scale from 0 to 100 in Firstbeat Life service (100 is the best score)
The change in autonomic nervous system function and health behaviors based on measured sleep0, 4, 8, 12, 24 and 36 months from startThe change in autonomic nervous system function and health behaviors is assessed by measured sleep. Sleep is scored on a scale from 0 to 100 in Firstbeat Life service (100 is the best score)
The change in autonomic nervous system function and health behaviors based on measured physical activity0, 4, 8, 12, 24 and 36 months from startThe change in autonomic nervous system function and health behaviors is assessed by measured physical activity. Physical activity is scored on a scale from 0 to 100 in Firstbeat Life service (100 is the best score)
The change in autonomic nervous system function and health behaviors based on measured physical fitness0, 4, 8, 12, 24 and 36 months from startThe change in autonomic nervous system function and health behaviors is assessed by measured physical fitness as assessed by VO2Max
The change in depression and mood by BBI-150 and 12 months from startThe change in depression and mood are assessed by Bergen Burnout Indicator (BBI-15). BBI-15 result is on a scale from 0 to 100 where scores from 0 to 74 mean no burnout and scores from 95 to 100 mean severe burnout.
The change in self-reported questionnaire measures0, 12, 24 and 36 months from startSelf-reported questionnaire measures are mental wellbeing, physical health, sleep and recovery, financial situation, social relationships, work-related information etc. in the Aisti Index wellbeing assessment. Aisti assessment gives results on a scale from 0 to 100 (100 is best) for each area of life.
The change in blood pressure0 and 12 months from startThe change in blood pressure is measured between the start and the end of the 12 month intervention period.
The change in weight0 and 12 months from startThe change in weight is measured between the start and the end of the 12 month intervention period.
The change in waist circumference0 and 12 months from startThe change in waist circumference is measured between the start and the end of the 12 month intervention period.
The change in neck circumference0 and 12 months from startThe change in neck circumference is measured between the start and the end of the 12 month intervention period.
Return of investment (ROI)0, 12, 24 and 36 months from startReturn of investment (ROI) is calculated through absenteeism statistics and self-reported presenteeism.
Company's financial performance0, 12, 24 and 36 months from startCompany's financial performance is evaluation is based on reported revenue and profit.

Countries

Finland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026